IOF Blog

Rotator Cuff Tear Case Study

Rotator Cuff Tear Case Study

Introducing IOF’s Case Study Feature  The Interventional Orthopedics Foundation is committed to serving as a resource for physicians pioneering the medical subspecialty of Interventional Orthopedics. In order to best help our members expand their knowledge about...

Rotator Cuff Tear Case Study

Introducing IOF’s Case Study Feature  The Interventional Orthopedics Foundation is committed to serving as a resource for physicians pioneering the medical subspecialty of Interventional Orthopedics. In order to best help our members expand their knowledge about...

read more

IOF Publishes Study in Bone Joint and Research

The Interventional Orthopedics Foundation is excited to announce that a study funded by the organization has been published in the Bone & Joint Research Journal. IOF members Dr. Dustin R. Berger, Dr. Christopher Centeno, Neven Steinmetz conducted the study, which...

Why Should I Attend IOF 2019?

We’re just three months out from our 2019 annual conference: Controversies in Orthobiologics. For three days (February 6-9) we’ll bring together national and global experts to discuss the latest original research and controversial topics in the field of regenerative...

IOF Early Bird Discount

Planning to Attend IOF 2019? Take advantage of this registration discount before November 15! The countdown to IOF 2019 is on! Our annual conference will take place February 6-9 in Broomfield, Colorado. This year’s topic is Controversies in Orthobiologics and we will...

Q&A with IOF Instructor Dr. James Leiber

We recently sat down with Dr. James Leiber, DO, one of IOF’s esteemed instructors and the founder and medical director of New Regeneration Orthopedics of Florida, to find out about how he became involved in IOF and regenerative medicine. IOF: How did you become...

IOF2017: MSCs are Not Stem Cells?

Arnie Caplan is widely considered the father of mesenchymal stem cells. He now takes the view that MSCs aren't stem cells and that he should have never given them that name. He also believes that the primary function of these cells is paracrine, so he calls them...

Learn About Platelet Rich Plasma (PRP) Dosage in Tendons at #IOF2017

If you’re using 3-5X PRP in tendons you may be under dosing certain patients.
Two articles have been published suggesting that higher concentrations of PRP cause tenocyte inhibition. Given that both studies had serious design flaws, Interventional Orthopedics Foundation (IOF) scientists repeated these experiments.

Share This